iRhythm Technologies to Report Second Quarter 2021 Financial Results on August 5, 2021
iRhythm Technologies, Inc. (NASDAQ: IRTC) will report its Q2 2021 financial results on August 5, 2021, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
iRhythm Technologies, Inc. (NASDAQ: IRTC) will report its Q2 2021 financial results on August 5, 2021, after market close. A conference call, starting at 1:30 p.m. PT / 4:30 p.m. ET, will accompany the results. The company specializes in digital health care solutions for cardiac care, utilizing advanced biosensor devices and cloud-based analytics for arrhythmia diagnosis. This innovative approach aims to significantly enhance patient management by providing actionable insights from extensive cardiac data.
Positive
- Leading digital health care company focused on cardiac care.
- Innovative biosensor technology for improved arrhythmia detection.
Negative
- None.
Details
News Market Reaction – IRTC
The recorded move for IRTC in the trading session of this news was -2.13%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN FRANCISCO, July 22, 2021 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the second quarter 2021 after the close of trading on Thursday, August 5, 2021. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.
Investors interested in listening to the conference call may do so by accessing the live and archived webcast of the event available on the “Investors” section of the company’s website at: www.irhythmtech.com.
About iRhythm Technologies, Inc.
iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based data analytics with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company believes improvements in arrhythmia detection and characterization have the potential to change clinical management of patients.
Investor Relations Contact
Leigh Salvo
(415) 937-5404
investors@irhythmtech.com
Media Contact
Morgan Mathis
(310) 528-6306
irhythm@highwirepr.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.